Determinants of masked hypertension in hypertensive patients treated in a primary care setting

Internal Medicine Journal

Volumn 42, Issue 3, 2012, Pages 260-266

  Andalib, A ^a   Akhtari, S ^a   Rigal, R ^b   Curnew, G ^c   Leclerc, J M ^b   Vaillancourt, M ^b   Tardif, J C ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b Novartis Pharmaceuticals   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Blood pressure monitoring; Cardiovascular risk; Hypertension; Primary care

Indexed keywords

VALSARTAN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY MASS; CANADA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES COMPLICATIONS; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FEMALE; HEART FAILURE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MASKED HYPERTENSION; MIDDLE AGED; OBESITY; PREVALENCE; PRIMARY HEALTH CARE; QUEBEC; RISK; TETRAZOLES; VALINE; WHITE COAT HYPERTENSION;

EID: 84858710849     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02407.x     Document Type: Article

References (33)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23.
2. Franco OH, Peeters A, Bonneux L, de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 2005; 46: 280-86.
3. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-60.
4. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129mmHg. JAMA 1967; 202: 1028-34.
5. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114mmHg. JAMA 1970; 213: 1143-52.
6. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
7. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH etal. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64.
8. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D etal. Treatment of hypertension in patients 80years of age or older. N Engl J Med 2008; 358: 1887-98.
9. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988 and 1994 and 1999-2004. Hypertension 2008; 52: 818-27.
10. Joffres MR, Hamet P, MacLean DR, L'italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001; 14: 1099-105.
11. Pickering TG. The ninth Sir George Pickering memorial lecture. Ambulatory monitoring and the definition of hypertension. J Hypertens 1992; 10: 401-9.
12. Aksoy I, Deinum J, Lenders JW, Thien T. Does masked hypertension exist in healthy volunteers and apparently well-controlled hypertensive patients? Neth J Med 2006; 64: 72-7.
13. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H etal. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54: 226-32.
14. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B etal. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-9.
15. Konstantopoulou AS, Konstantopoulou PS, Papargyriou IK, Liatis ST, Stergiou GS, Papadogiannis DE. Masked, white coat and sustained hypertension: comparison of target organ damage and psychometric parameters. J Hum Hypertens 2010; 24: 151-7.
16. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R etal. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104: 1385-92.
17. Bjorklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107: 1297-302.
18. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH etal. Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-15.
19. Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens 2008; 26: 1715-25.
20. Padwal RS, Hemmelgarn BR, Khan NA, Grover S, McKay DW, Wilson T etal. Canadian Hypertension Education Program. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2009; 25: 279-86.
21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL etal. National Heart Lung and Blood Institute Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
22. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 2001; 322: 531-6.
23. Tardif JC, Curnew GP, Leclerc JM, Rehel B. Reaching the therapeutic goal in hypertension: results from the Canadian valsartan observational study. (Diovantage 4). Can J Clin Pharmacol 2008; 15: e177-e187.
24. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007; 30: 479-88.
25. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care 2005; 28: 337-42.
26. Greving JP, Denig P, de Zeeuw D, Bilo HJ, Haaijer-Ruskamp FM. Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study. Cardiovasc Diabetol 2007; 6: 25.
27. Mallion JM, Clerson P, Bobrie G, Genes N, Vaisse B, Chatellier G. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens 2006; 24: 2365-70.
28. Kabutoya T, Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K etal. Determinants of negative white-coat effect in treated hypertensive patients: the Jichi Morning Hypertension Research (J-MORE) study. Am J Hypertens 2009; 22: 35-40.
29. Obara T, Ohkubo T, Funahashi J, Kikuya M, Asayama K, Metoki H etal. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens 2005; 23: 1653-60.
30. Asayama K, Sato A, Ohkubo T, Mimura A, Hayashi K, Kikuya M etal. The association between masked hypertension and waist circumference as an obesity-related anthropometric index for metabolic syndrome: the Ohasama study. Hypertens Res 2009; 32: 438-43.
31. Obara T, Ohkubo T, Asayama K, Kikuya M, Metoki H, Inoue R etal. Prevalence of masked hypertension in subjects treated with antihypertensive drugs as assessed by morning versus evening home blood pressure measurements: the J-HOME study. Clin Exp Hypertens 2008; 30: 277-87.
32. Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens 2005; 18: 772-8.
33. Ito K, Obara T, Ohkubo T, Gonokami K, Shinki T, Shibamiya T etal. Influence of home blood pressure measuring conditions in the evening on the morning-evening home blood pressure difference in treated hypertensive patients: the J-HOME study. Blood Press Monit 2009; 14: 160-65.